Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
134.28
-2.02 (-1.48%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 17, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6,901,848
Open
137.61
Bid (Size)
134.29 (100)
Ask (Size)
135.61 (100)
Prev. Close
136.30
Today's Range
134.09 - 140.61
52wk Range
107.75 - 157.29
Shares Outstanding
1,253,809,440
Dividend Yield
2.44%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Gilead Leads The Battle Vs. HIV. But Rivals Are On The Move.
↗
Today 12:50 EDT
Gilead stock is closely tied to its HIV treatments. But with Biktarvy's patent expirations looming, can the giant survive?
Via
Investor's Business Daily
Topics
Intellectual Property
Kalshi Will Let Traders Bet on FDA Drug Approvals Despite Critics' Insider Trading Warnings
↗
July 16, 2026
Kalshi is expanding into biotech with contracts on FDA drug approvals from Sanofi and Gilead, as critics warn the wagers invite insider trading.
Via
Benzinga
Performance
YTD
+10.4%
+10.4%
1 Month
+5.5%
+5.5%
3 Month
-3.1%
-3.1%
6 Month
+10.7%
+10.7%
1 Year
+22.2%
+22.2%
More News
Read More
Invesco Healthcare ETF vs VanEck Biotech: Which ETF Will Deliver the Healthiest Returns for 2026?
↗
July 14, 2026
Via
The Motley Fool
Topics
ETFs
Spotting Winners: Gilead Sciences (NASDAQ:GILD) And Therapeutics Stocks In Q1
July 13, 2026
Via
StockStory
Topics
Artificial Intelligence
Gilead Sciences Inc (NASDAQ:GILD): A Sustainable Dividend Leader in the Biotechnology Sector
↗
June 29, 2026
Via
Chartmill
Many Investors Are Still Treating Gilead Sciences Like a Has-Been HIV Stock. 4 Drug Launches This Year Could Prove Them Wrong.
↗
July 12, 2026
Via
The Motley Fool
Topics
Intellectual Property
Which is Best for Investors: Healthcare Stability (XLV) or Biotech Growth (IBBQ)?
↗
July 11, 2026
Via
The Motley Fool
Topics
ETFs
Which is the Better Choice for Healthcare Investors? IYH or BBH?
↗
July 11, 2026
Via
The Motley Fool
Topics
ETFs
What's going on in today's session: S&P500 movers
↗
July 10, 2026
Via
Chartmill
2 Recession-Resistant Dividend Stocks to Buy and Hold
↗
July 10, 2026
Via
The Motley Fool
Topics
Economy
IHE vs. IBB: Which iShares Healthcare ETF Is the Better Buy?
↗
July 10, 2026
Via
The Motley Fool
Topics
ETFs
Which Healthcare ETF Is the Better Buy: Invesco's IBBQ or State Street's XPH?
↗
July 08, 2026
Via
The Motley Fool
Topics
ETFs
BBH vs. XPH: Which Healthcare ETF Is Better for Beginners?
↗
July 08, 2026
Via
The Motley Fool
Topics
ETFs
Stay informed with the top movers within the S&P500 index on Tuesday.
↗
July 07, 2026
Via
Chartmill
Generic Fears Overdone? Gilead Stock Has More Room to Run, Analyst Says
↗
July 06, 2026
Via
Benzinga
MissionIRNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Shareholders Should Watch Novartis Latest $1.5 Billion ADC Acquisition
July 06, 2026
Via
Investor Brand Network
FHLC vs. BBH: Which Healthcare ETF Is the Better Buy?
↗
July 04, 2026
Via
The Motley Fool
Topics
ETFs
If You Invested $1000 In Gilead Sciences Stock 20 Years Ago, You Would Have This Much Today
↗
July 03, 2026
Via
Benzinga
SPDR Health Care ETF Tops iShares Biotech in Long-Term Returns
↗
July 02, 2026
Via
The Motley Fool
Topics
ETFs
Gilead's Trodelvy Expands Reach With New FDA Approval In Breast Cancer
↗
June 25, 2026
Via
Benzinga
This ETF Has More Than Doubled the S&P 500's Returns Over the Past Decade. Is It a Buy for the Next Decade?
↗
June 25, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
Stocks
U.S. FDA Approves Trodelvy® for First-Line Treatment of Metastatic Triple-Negative Breast Cancer
June 24, 2026
From
Gilead Sciences, Inc.
Via
Business Wire
Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
June 24, 2026
Via
Investor Brand Network
BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Targets Next Generation of DNA Damage Response Cancer Therapies
June 24, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
June 24, 2026
From
BioMedWire
Via
GlobeNewswire
Frequently Asked Questions
Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 134.28
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 07/17/26 04:00 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 168.36B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 168B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.